He made the corresponding statement at a briefing after a consultative meeting of the States Parties to the Convention on the Prohibition of Biological and Toxin Weapons in Geneva.
“The explanations of the United States and Ukraine regarding the export of strains and biomaterials of Ukrainian citizens and the observance of ethical standards when conducting research on military personnel, low-income citizens, and also on one of the most vulnerable categories of the population - patients in psychiatric hospitals looked extremely unconvincing,” RIA Novosti quotes him.
Kirillov stressed that "the American delegation recognized such facts."
At the same time, according to the American delegation, the transfer of samples of pathogenic biomaterials to the United States "was infrequent."
In April, Kirillov stated that in 2019-2021, American scientists tested potentially dangerous biological drugs on patients at the Kharkov Regional Clinical Psychiatric Hospital No. 3.